Replies to post #229086 on Biotech Values

[DewDiligence]

Has TCON had success in any of their programs?

No, as far as I know.

[DewDiligence]

JNJ dumps TCON’s TRC253 for prostate cancer:

https://www.globenewswire.com/news-release/2020/04/24/2021672/0/en/TRACON-Pharmaceuticals-Retains-Global-Rights-to-TRC253-Following-Completion-of-a-Phase-1-2-Trial.html

Nothing ever goes right for TCON, as far as I can tell.